Gyre Therapeutics (GYRE) Institutional Ownership $11.12 +1.13 (+11.31%) (As of 12/17/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Gyre Therapeutics (NASDAQ:GYRE)CurrentInstitutional OwnershipPercentage23.99%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$3.07MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$229.27K Get GYRE Insider Trade Alerts Want to know when executives and insiders are buying or selling Gyre Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GYRE Institutional Buying and Selling by Quarter Ad Porter & CompanyForbes rich list released… #1 to be assassinated?Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Gyre Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC9,288$116K0.0%+281.8%0.010% 11/16/2024 Geode Capital Management LLC303,647$3.81M0.0%+16.9%0.325% 11/15/2024 Barclays PLC9,288$116K0.0%+281.8%0.010% 11/15/2024 State Street Corp104,490$1.31M0.0%+8.8%0.112% 11/13/2024 FMR LLC3,742$47K0.0%N/A0.004% 11/13/2024 Advantage Alpha Capital Partners LP26,634$334K0.1%N/A0.029% 11/12/2024 Charles Schwab Investment Management Inc.113,648$1.43M0.0%+392.2%0.122% 8/14/2024 Marshall Wace LLP10,720$128K0.0%-58.0%0.013% 8/9/2024 Renaissance Technologies LLC13,900$166K0.0%N/A0.016% 8/9/2024 WINTON GROUP Ltd18,467$220K0.0%N/A0.022% 8/1/2024 Rhumbline Advisers10,291$123K0.0%N/A0.012% 7/26/2024 Bank of New York Mellon Corp18,266$218K0.0%N/A0.021% 5/10/2024 Vanguard Group Inc.195,098$3.41M0.0%-1.5%0.228% (Data available from 1/1/2016 forward) GYRE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GYRE shares? During the previous two years, 12 institutional investors and hedge funds held shares of Gyre Therapeutics. The most heavily invested institutionals were Geode Capital Management LLC ($3.81M), Vanguard Group Inc. ($3.41M), Charles Schwab Investment Management Inc. ($1.43M), State Street Corp ($1.31M), Advantage Alpha Capital Partners LP ($334K), WINTON GROUP Ltd ($220K), and Bank of New York Mellon Corp ($218K).Learn more on GYRE's institutional investors. What percentage of Gyre Therapeutics stock is owned by institutional investors? 23.99% of Gyre Therapeutics stock is owned by institutional investors. Learn more on GYRE's institutional investor holdings. Which institutional investors have been buying Gyre Therapeutics stock? Of the 10 institutional investors that purchased Gyre Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Charles Schwab Investment Management Inc. ($90.56K), Geode Capital Management LLC ($43.84K), Advantage Alpha Capital Partners LP ($26.63K), WINTON GROUP Ltd ($18.47K), Bank of New York Mellon Corp ($18.27K), Renaissance Technologies LLC ($13.90K), and Barclays PLC ($13.71K). How much institutional buying is happening at Gyre Therapeutics? Institutional investors have bought a total of 247,819 shares in the last 24 months. This purchase volume represents approximately $3.07M in transactions. Which Gyre Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Gyre Therapeutics stock in the last 24 months: Marshall Wace LLP ($14.82K), and Vanguard Group Inc. ($3.00K). How much institutional selling is happening at Gyre Therapeutics? Institutional investors have sold a total of 17,823 shares in the last 24 months. This volume of shares sold represents approximately $229.27K in transactions. Related Companies Organon & Co. Institutional Ownership PTC Therapeutics Institutional Ownership Rhythm Pharmaceuticals Institutional Ownership MoonLake Immunotherapeutics Institutional Ownership ImmunityBio Institutional Ownership Janux Therapeutics Institutional Ownership Verona Pharma Institutional Ownership Xenon Pharmaceuticals Institutional Ownership Zai Lab Institutional Ownership ACADIA Pharmaceuticals Institutional Ownership This page (NASDAQ:GYRE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gyre Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GYRE Stock Alerts